Cargando…

Nanoparticles Loaded with the BET Inhibitor JQ1 Block the Growth of Triple Negative Breast Cancer Cells In Vitro and In Vivo

Inhibition of bromo-and extra-terminal domain (BET) proteins, epigenetic regulators of genes involved in cell viability, has been efficiently tested in preclinical models of triple negative breast cancer (TNBC). However, the use of the selective BET-inhibitor JQ1 on humans is limited by its very sho...

Descripción completa

Detalles Bibliográficos
Autores principales:	Maggisano, Valentina, Celano, Marilena, Malivindi, Rocco, Barone, Ines, Cosco, Donato, Mio, Catia, Mignogna, Chiara, Panza, Salvatore, Damante, Giuseppe, Fresta, Massimo, Andò, Sebastiano, Russo, Diego, Catalano, Stefania, Bulotta, Stefania
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2019
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7016573/ https://www.ncbi.nlm.nih.gov/pubmed/31905936 http://dx.doi.org/10.3390/cancers12010091

Ejemplares similares

Co-Encapsulation of Paclitaxel and JQ1 in Zein Nanoparticles as Potential Innovative Nanomedicine
por: Celano, Marilena, et al.
Publicado: (2022)

Quercetin Protects Human Thyroid Cells against Cadmium Toxicity
por: Capriglione, Francesca, et al.
Publicado: (2021)

Identification of Exosomal microRNAs and Their Targets in Papillary Thyroid Cancer Cells
por: Maggisano, Valentina, et al.
Publicado: (2022)

Oleacein Prevents High Fat Diet-Induced Adiposity and Ameliorates Some Biochemical Parameters of Insulin Sensitivity in Mice
por: Lepore, Saverio Massimo, et al.
Publicado: (2019)

MicroRNAs as Biomarkers in Thyroid Carcinoma
por: Celano, Marilena, et al.
Publicado: (2017)

Reading Cancer: Chromatin Readers as Druggable Targets for Cancer Treatment
por: Mio, Catia, et al.
Publicado: (2019)

Low Doses of Methylmercury Induce the Proliferation of Thyroid Cells In Vitro Through Modulation of ERK Pathway
por: Maggisano, Valentina, et al.
Publicado: (2020)

Cytotoxic effects of Gemcitabine-loaded liposomes in human anaplastic thyroid carcinoma cells
por: Celano, Marilena, et al.
Publicado: (2004)

Expression of Leptin Receptor and Effects of Leptin on Papillary Thyroid Carcinoma Cells
por: Celano, Marilena, et al.
Publicado: (2019)

Phosphodiesterase 5 (PDE5) Is Highly Expressed in Cancer-Associated Fibroblasts and Enhances Breast Tumor Progression
por: Catalano, Stefania, et al.
Publicado: (2019)

Biodegradable Polymeric Nanoparticles for Drug Delivery to Solid Tumors
por: Gagliardi, Agnese, et al.
Publicado: (2021)

Knockdown of Leptin Receptor Affects Macrophage Phenotype in the Tumor Microenvironment Inhibiting Breast Cancer Growth and Progression
por: Gelsomino, Luca, et al.
Publicado: (2020)

BET bromodomain inhibitor (JQ1) and tumor angiogenesis
por: Bid, Hemant Kumar, et al.
Publicado: (2016)

Activated FXR Inhibits Leptin Signaling and Counteracts Tumor-promoting Activities of Cancer-Associated Fibroblasts in Breast Malignancy
por: Giordano, Cinzia, et al.
Publicado: (2016)

Effects of Oleacein on High-Fat Diet-Dependent Steatosis, Weight Gain, and Insulin Resistance in Mice
por: Lombardo, Giovanni Enrico, et al.
Publicado: (2018)

Leptin and Notch Signaling Cooperate in Sustaining Glioblastoma Multiforme Progression
por: Panza, Salvatore, et al.
Publicado: (2020)

Physicochemical features and transfection properties of chitosan/poloxamer 188/poly(D,L-lactide-co-glycolide) nanoplexes
por: Cosco, Donato, et al.
Publicado: (2014)

Editorial: Bypassing the Biological Barriers by Means of Biocompatible Drug Delivery Systems
por: Awasthi, Vibhudutta, et al.
Publicado: (2021)

Novel Insights into the Antagonistic Effects of Losartan against Angiotensin II/AGTR1 Signaling in Glioblastoma Cells
por: Panza, Salvatore, et al.
Publicado: (2021)

A novel leptin antagonist peptide inhibits breast cancer growth in vitro and in vivo
por: Catalano, Stefania, et al.
Publicado: (2015)

The Omega-3 Docosahexaenoyl Ethanolamide Reduces CCL5 Secretion in Triple Negative Breast Cancer Cells Affecting Tumor Progression and Macrophage Recruitment
por: Augimeri, Giuseppina, et al.
Publicado: (2023)

Beneficial effects of the olive oil phenolic components oleuropein and hydroxytyrosol: focus on protection against cardiovascular and metabolic diseases
por: Bulotta, Stefania, et al.
Publicado: (2014)

BET protein Brd4 activates transcription in neurons and BET inhibitor Jq1 blocks memory in mice
por: Korb, Erica, et al.
Publicado: (2015)

The BET-bromodomain inhibitor JQ1 mitigates vemurafenib drug resistance in melanoma
por: Zhao, Bei, et al.
Publicado: (2018)

Modulation of Virulence-Associated Traits in Aspergillus fumigatus by BET Inhibitor JQ1
por: Orekhova, Anastasia, et al.
Publicado: (2022)

Emerging roles of the cellular prion protein (PrP(C)) and 37/67 kDa laminin receptor (RPSA) interaction in cancer biology
por: Limone, Adriana, et al.
Publicado: (2023)

PDE5 Inhibitors-Loaded Nanovesicles: Physico-Chemical Properties and In Vitro Antiproliferative Activity
por: De Rose, Roberta F., et al.
Publicado: (2016)

The BET/BRD inhibitor JQ1 improves brain plasticity in WT and APP mice
por: Benito, E, et al.
Publicado: (2017)

Isocitrate dehydrogenase 1 mutation sensitizes intrahepatic cholangiocarcinoma to the BET inhibitor JQ1
por: Fujiwara, Hiroaki, et al.
Publicado: (2018)

The BET Inhibitor JQ1 Potentiates the Anticlonogenic Effect of Radiation in Pancreatic Cancer Cells
por: Garcia, Patrick L., et al.
Publicado: (2022)

Oral Administration of Oleuropein and Its Semisynthetic Peracetylated Derivative Prevents Hepatic Steatosis, Hyperinsulinemia, and Weight Gain in Mice Fed with High Fat Cafeteria Diet
por: Lepore, Saverio Massimo, et al.
Publicado: (2015)

Obesity, Leptin and Breast Cancer: Epidemiological Evidence and Proposed Mechanisms
por: Andò, Sebastiano, et al.
Publicado: (2019)

BET-inhibition by JQ1 promotes proliferation and self-renewal capacity of hematopoietic stem cells
por: Wroblewski, Mark, et al.
Publicado: (2018)

Stromal remodeling by the BET bromodomain inhibitor JQ1 suppresses the progression of human pancreatic cancer
por: Yamamoto, Keisuke, et al.
Publicado: (2016)

The BET Inhibitor JQ1 Augments the Antitumor Efficacy of Gemcitabine in Preclinical Models of Pancreatic Cancer
por: Miller, Aubrey L., et al.
Publicado: (2021)

BET protein inhibitor JQ1 inhibits growth and modulates WNT signaling in mesenchymal stem cells
por: Alghamdi, Saeed, et al.
Publicado: (2016)

Akt/mTOR-Mediated Autophagy Confers Resistance To BET Inhibitor JQ1 In Ovarian Cancer
por: Luan, Wenqing, et al.
Publicado: (2019)

BET inhibitor JQ1 enhances anti-tumor immunity and synergizes with PD-1 blockade in CRC
por: Wang, Huijin, et al.
Publicado: (2022)

BET bromodomain inhibitor JQ1 regulates spermatid development by changing chromatin conformation in mouse spermatogenesis
por: Wang, Xiaorong, et al.
Publicado: (2021)

The BET inhibitor JQ1 selectively impairs tumour response to hypoxia and downregulates CA9 and angiogenesis in triple negative breast cancer
por: da Motta, L L, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_88e8q6kkqiqsbo6c8jp4hv7g4p